Effects of dairy lipids on weight loss and heart health in obese adults
Official title: Bioactive Dairy Lipids to Manage Cardiometabolic Risk in Obesity
Run by Hospices Civils de Lyon · NCT05783466 · Data updated 2026-11-12
This study is testing if eating whole dairy products with special fats can help obese adults lose weight and improve their heart health better than low-fat dairy products.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 75 (estimated) |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 2 sites (Pierre-Bénite and 1 other locations) |
| Status | Recruiting |
| Started | June 28, 2023 |
| Main results expected | October 2026 |
| Study ends | October 2026 |
| Registry record updated | June 18, 2025 |
| Trial ID | NCT05783466 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are men and women aged 18-70 with a BMI between 35 and 60 kg/m2 who consume dairy products regularly.
✕Probably not a fit
Patients with a history of bariatric surgery, significant alcohol consumption, or dietary restrictions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized intervention focusing on adults with severe obesity, aiming to compare the effects of whole dairy products enriched with milk polar lipids against low-fat dairy products on fasting plasma apolipoprotein B concentrations over a 3-month period. Participants will consume specified dairy products daily while metabolic parameters will be assessed before and after the intervention. The study seeks to determine if whole dairy products can lead to greater improvements in cardiometabolic risk factors compared to low-fat options.
Why it matters
Potential benefit: If successful, this study could provide insights into dietary interventions that significantly improve weight loss and metabolic health in individuals with severe obesity.
How similar studies have gone: While there is ongoing research into dietary impacts on obesity, this specific approach of using milk polar lipids is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men and women between 18-70 years * Body Mass Index (BMI) between 35 and 60 kg/m2 inclusive * Stable body weight (weight change +/- 5 % for 3 months prior to screening) * Consumption of at least 1 serving/day of dairy products made from cow's milk * Informed consent Exclusion Criteria: * History of bariatric or digestive surgery or disease interfering with main outcomes * Drinking more than 3 glasses of alcohol per day (\>30g/day) * Pregnancy, parturiency or breastfeeding * Food allergies or intolerance to dairy products * Dietary restriction (vegetarian or lactovegetarian) or high protein diet * Use of dietary supplements * Treated with lipid lowering drugs (fibrates, statins, anti-PCSK9, ezetimibe, cholestyramine) within the last 6 weeks before study entry * Treated with insulin, GLP-1 analogs, acarbose, corticoids, beta-blockers. * Medications interfering with intestinal microbiota (beta-lactamines within 3 months before the study or laxatives) * Smoking ≥ 5 cigarettes/day during the past 6 months.
Where it's running
-
Centres Hospitalier Lyon Sud, Service d'Endocrinologie-Diabète-Nutrition
Pierre-Bénite, France Recruiting -
Centre de Recherche en Nutrition Humaine Rhône-Alpes
Pierre-Bénite, France Active not recruiting
Study contacts
- Study coordinator: Emmanuel DISSE, Pr
- Email: emmanuel.disse@chu-lyon.fr
- Phone: +33 4 78 86 14 89
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
TSBL-based vs BMI-based limb length in one-anastomosis gastric bypass
This trial tests whether calculating the biliopancreatic limb length by total small bowel length (TSBL) helps weight loss and safety more than using standard BMI-based lengths in adults undergoing a single-center OAGB for obesity.
-
Gut stool tests after sleeve vs gastric bypass
This study tests whether routine stool tests can reveal changes in gut function six months after sleeve gastrectomy or gastric bypass in adults with morbid obesity.
-
Impact of Bariatric Surgery on Female Sexual Function and Hormones
This observational study will see how weight loss surgery affects sexual function and hormone levels in women with severe obesity, six months after surgery.
-
Dual-chamber patient-controlled pain relief after laparoscopic sleeve gastrectomy
This test checks whether a dual-chamber IV patient-controlled pump delivering fentanyl plus ketorolac reduces pain and postoperative nausea and vomiting in adults having laparoscopic sleeve gastrectomy.
-
Exercise program to improve weight, strength, and recovery around bariatric surgery
This program will test whether a structured exercise plan supported by telerehabilitation helps adults with severe obesity who are having bariatric surgery lose more body fat and gain more strength than usual care.
-
Comparing rivaroxaban and enoxaparin for preventing blood clots in obese patients undergoing weight loss surgery
This study tests whether the blood thinner rivaroxaban works better than enoxaparin to prevent blood clots in obese patients having weight loss surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.